Leerink Partners Maintains Market Perform on Inspire Medical Systems, Raises Price Target to $197
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners has maintained a Market Perform rating on Inspire Medical Systems (NYSE:INSP) while raising the price target from $167 to $197.
September 10, 2024 | 5:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Leerink Partners has maintained a Market Perform rating on Inspire Medical Systems and increased the price target from $167 to $197, indicating a positive outlook.
The increase in price target from $167 to $197 by Leerink Partners suggests a positive outlook for Inspire Medical Systems, which could lead to a short-term increase in stock price. The Market Perform rating indicates a neutral stance, but the raised target shows confidence in potential growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100